Clinical Trials Sponsored by Sinovac Life Sciences Co., Ltd.

Total 516 results

Sinovac Life Sciences Co., Ltd.

Recruiting

SA55 Injection Phase II Study in the Treatment of Mild/Moderate COVID-19 Patients

Infection of Upper Respiratory Tract Caused by 2019-nCoV

China
Sinovac Life Sciences Co., Ltd.

Completed

Safety and Immunogenicity Study of Inactivated Vaccine for Prevention of SARS-CoV-2 Infection(COVID-19)

COVID-19

China
Sinovac Life Sciences Co., Ltd.

Recruiting

SA55 Novel Coronavirus Broad-spectrum Neutralizing Antibody Nasal Spray in Health People

COVID-19

China
Sinovac Life Sciences Co., Ltd.

Recruiting

Safety and Immunogenicity Study of a 13-valent Pneumococcal Polysaccharide Conjugate Vaccine

Pneumococcal Infections

China
Sinovac Life Sciences Co., Ltd.

Active, not recruiting

Immunogenicity，Safety and Cross - Immune Response With Mutant Strains of a Third Dose of an Inactivated COVID-19 Vaccine

COVID-19

China
Sinovac Life Sciences Co., Ltd.

Completed

Safety of an Inactivated SARS-CoV-2 Vaccine for Prevention of COVID-19 in Children and Adolescents

COVID-19

China
Sinovac Life Sciences Co., Ltd.

Completed

Safety and Immunogenicity Study of Booster Vaccination in Different Doses of COVID-19 Vaccine (Vero Cell),Inactivated for Prevention of COVID-19

COVID-19

China
Sinovac Life Sciences Co., Ltd.

Recruiting

SA55 Injection: a Potential Therapy for the Prevention and Treatment of COVID-19

COVID-19

China
Sinovac Life Sciences Co., Ltd.

Recruiting

Safety and Immunogenicity of Tetanus Vaccine, Adsorbed in 18~44 Years Old Population

Tetanus

China
Sinovac Life Sciences Co., Ltd.

Completed

Safety of an Inactivated SARS-CoV-2 Vaccine (CoronaVac) in Children and Adolescents

COVID-19

China
Sinovac Life Sciences Co., Ltd.

Active, not recruiting

Efficacy and Safety of Anti-COVID-19 Antibody SA58 Nasal Spray to Prevent Infection in High-risk Populations

COVID-19

China
Sinovac Life Sciences Co., Ltd.

Completed

Immunogenicity and Safety of a Third Dose of COVID-19 Vaccine(Vero Cell), Inactivated in the Elderly

COVID-19

China
Sinovac Biotech (Colombia) S.A.S.
Sinovac Life Sciences Co., Ltd.

Not yet recruiting

Immunogenicity and Safety Study of One Booster Dose of Trivalent COVID-19 Vaccine (Vero Cell), Inactivated

COVID-19

Colombia
Sinovac Life Sciences Co., Ltd.
Beijing Ditan Hospital

Active, not recruiting

Efficacy and Safety of SA58 Nasal Spray in Close Contact With COVID-19 People

COVID-19

China
Butantan Institute
Sinovac Life Sciences Co., Ltd.

Completed

Clinical Trial of Efficacy and Safety of Sinovac's Adsorbed COVID-19 (Inactivated) Vaccine in Healthcare Professionals (PROFISCOV)

COVID-19

Brazil
Pontificia Universidad Catolica de Chile
Sinovac Life Sciences Co., Ltd.

Completed

Immunogenicity Evaluation of Omicron Variant-based Vaccine and a Trivalent Vaccine in Adults Against COVID-19 in Chile (CoronaVarCL)

COVID-19 | Vaccines

Chile
Sinovac Research and Development Co., Ltd.

Recruiting

A Phase 1b Clinical Trial of 13-valent Pneumococcal Polysaccharide Conjugate Vaccine

Pneumococcal Infectious Disease

China
Sinovac Research and Development Co., Ltd.

Completed

Safety and Immunogenicity Study of Inactivated Vaccine for Prevention of COVID-19

COVID-19

China
Sinovac Research and Development Co., Ltd.

Completed

Safety of an Inactivated SARS-CoV-2 Vaccine for Prevention of COVID-19 in Adults

COVID-19

China
Sinovac Research and Development Co., Ltd.

Active, not recruiting

Effectiveness of Inactivated COVID-19 Vaccine of the First Booster Dose

COVID-19

Brazil
Sinovac Research and Development Co., Ltd.

Completed

Effectiveness of COVID-19 Vaccine for Prevention of COVID-19 in the Dominican Republic

COVID-19

Dominican Republic
Sinovac Research and Development Co., Ltd.

Suspended

Immunogenicity and Safety Study of the 3rd Booster Dose Using the High or Medium Dose of Inactivated (CoronaVac®) Vaccine in Healthy Adults in Turkey

COVID-19

Turkey
Sinovac Research and Development Co., Ltd.

Completed

Safety and Immunogenicity Study of Live Attenuated Mumps Vaccines in Healthy Infants

Mumps

China
Sinovac Research and Development Co., Ltd.

Completed

Study on Combined Vaccination With SARS-CoV-2 Inactivated Vaccine and Quadrivalent Influenza Vaccine

COVID-19 | Influenza

China
Ivy Life Sciences, Co., Ltd

Completed

Study of Autologous Immune Killer Cells in Patients With Late Stage Hepatocellular Carcinoma or Lung Cancer

Lung Cancer | Liver Cancer | NSCLC Stage IV | Hepatocellular Carcinoma by BCLC Stage | NSCLC Stage IIIB
Sinovac Biotech Co., Ltd

Recruiting

A Multi-center, Open-labelled, Randomized, Controlled, Extended Phase Ⅲ Clinical Trial of sIPV Vaccine

Poliomyelitis | Polio

Pakistan, Bangladesh
Sinovac Biotech Co., Ltd

Completed

Clinical Trial of Enterovirus 71（EV71） Inactivated Vaccine in Children Aged 36-71 Months

Hand, Foot and Mouth Disease

China
Sinovac Biotech Co., Ltd

Completed

Clinical Trial of Recombinant Hepatitis B Vaccine (Hansenula Polymorpha, 10μg)

Hepatitis B

China
Sinovac Biotech Co., Ltd

Completed

Safety of an Inactivated Enterovirus Type 71 Vaccines in Healthy Children

Hand-foot-mouth Disease | Infection; Viral, Enterovirus

China
Sinovac Biotech Co., Ltd

Completed

Comparison of Immunization Schedules of Inactivated Hepatitis A Vaccine and Combined Hepatitis A and Hepatitis B Vaccine

Hepatitis B | Hepatitis A

China
Sinovac Biotech Co., Ltd

Completed

Clinical Trial to Evaluate the Safety and Immunogenicity of Quadrivalent Influenza Vaccine (7.5μg/0.25ml)

Seasonal Influenza

China
Sinovac Biotech Co., Ltd

Completed

Clinical Trial to Evaluate the Safety and Immunogenicity of Quadrivalent Influenza Vaccine (15µg/0.5ml)

Seasonal Influenza

China
Sinovac Biotech Co., Ltd

Completed

A Clinical Trial to Evaluate the Immunogenicity and Safety of sIPV in a "2+1"Sequential Schedule With bOPV in Infants

Poliomyelitis

China
Sinovac Biotech Co., Ltd

Completed

A Clinical Trial to Evaluate the Immunogenicity and Safety of sIPV in a '1+2' Sequential Schedule With bOPV in Infants

Poliomyelitis

China
Sinovac Biotech Co., Ltd

Completed

Five-year Immune Persistence Study of Inactivated Enterovirus Type 71 (EV71) Vaccine

Hand, Foot and Mouth Disease

China
Sinovac Biotech Co., Ltd

Completed

The Fifth-year Follow-up Study for the Phase IV Clinical Trial of Hepatitis A Vaccine in Healthy Children

Hepatitis A

China
Sinovac Biotech Co., Ltd

Completed

Comparison of Immunogenicity and Safety of Inactivated and Live Attenuated Hepatitis A Vaccines in Young Adults

Hepatitis A

China
Sinovac Biotech Co., Ltd

Completed

An Efficacy Trial in Inactivated Enterovirus Type 71 (EV71) Vaccine

Hand, Foot and Mouth Disease

China
Sinovac Biotech Co., Ltd

Completed

A Clinical Trial of Split-virion Influenza A/H1N1 Vaccines

Influenza

China
Sinovac Biotech Co., Ltd

Completed

Safety of an Inactivated Enterovirus Type 71 Vaccine in Healthy Adults

Infection; Viral, Enterovirus

China
Sinovac Biotech Co., Ltd

Completed

Safety and Immunogenicity of an Inactivated EV71 Vaccine in Infants

Infection, Viral, Enterovirus

China
Sinovac Research and Development Co., Ltd.

Active, not recruiting

Lot-to-lot Consistency of an Inactivated SARS-CoV-2 Vaccine Between Different Workshops in Healthy Children Aged 3-17 Years

COVID-19

China
Sinovac Research and Development Co., Ltd.

Completed

Efficacy, Immunogenicity and Safety of COVID-19 Vaccine , Inactivated in Children and Adolescents

COVID-19

Philippines, Malaysia, Chile, South Africa
Sinovac Research and Development Co., Ltd.

Completed

Safety and Immunogenicity of COVID-19 Vaccine, Inactivated in Healthy Population Aged From 3 to 11 Years

COVID-19

China
Sinovac Research and Development Co., Ltd.

Completed

Immunogenicity of an Inactivated COVID-19 Vaccine

COVID-19

China
Sinovac Research and Development Co., Ltd.

Withdrawn

Efficacy,Immunogenicity and Safety of COVID-19 Vaccine , Inactivated Booster Dose in Adults Aged 18 Years and Above

COVID-19
Sinovac Research and Development Co., Ltd.

Completed

Safety and Immunogenicity Study of Inactivated Vaccine for Prophylaxis of SARS CoV-2 Infection (COVID-19)

COVID-19

China
Sinovac Research and Development Co., Ltd.

Completed

Study of the Commercial Scale SARS-CoV-2 Vaccine Against the Pilot Scale Among Adults, and Bridging Study of the Immunogenicity in Elderly Against That in Adults

Covid19

China
Sinovac Biotech Co., Ltd

Not yet recruiting

Sequential Vaccination of Poliomyelitis Vaccine (Vero Cells), Inactivated, Sabin Strains From Different Manufacturers

Poliomyelitis
Sinovac Biotech Co., Ltd

Recruiting

Inactivated Bivalent Enterovirus Vaccine (Vero Cell) Phase I/II Clinical Trial

Hand, Foot and Mouth Disease | Herpangina

China

3

Subscribe